We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

L:NYSELoews Corporation Analysis

Data as of 2026-05-24 - not real-time

$108.87

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Loews Corp (L) is trading at $108.87, comfortably above its 20‑day ($107.52) and 50‑day ($108.10) SMAs and the 200‑day SMA ($104.14), indicating short‑term momentum. The RSI sits at 54.5, suggesting neutral but not overbought conditions, while the MACD histogram is positive (+0.41) and the signal line flags a bullish bias. At a forward PE of 37.5 versus a trailing PE of 13.9, earnings are expected to decline sharply, a view supported by Q1 2026 results that showed a year‑over‑year profit drop to $337 million and weaker underwriting performance. Nevertheless, the stock’s current PE is well below the industry average of 16.75 and the DCF‑derived fair value of $128.25 implies a ~15% upside, classifying it as fundamentally undervalued. The dividend yield of 0.23% is modest but the payout ratio of just 3.2% signals strong sustainability, and the company’s low beta (0.28) points to limited market volatility.
The balance sheet shows $6.5 billion in cash against $8.9 billion in debt, yielding a net‑debt position but manageable given steady operating cash flow of $2.6 billion. Revenue growth is tepid at 1.4% and ROE is modest (9.2%), underscoring the need for operational improvements. Risk factors are moderate: the insurance sector carries medium regulatory exposure, while geographic and currency risks are low. Overall, the technical setup is mildly bullish, valuation metrics suggest upside, and the dividend remains sustainable, supporting a positive outlook across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support with bullish MACD histogram
  • Neutral RSI and modest upside potential
  • Recent earnings decline dampening momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value suggests ~15% upside
  • PE well below industry average
  • Low beta and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified business lines beyond insurance
  • Undervalued relative to fundamentals
  • Strong cash generation supporting dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin8.82%
P/E Ratio13.9
ROE9.22%
ROA1.90%
Debt/Equity45.60
P/B Ratio1.2
Op. Cash Flow$2.6B
Free Cash Flow$2.1B
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI54.5
Support$102.88
Resistance$113.84
MA 20$107.52
MA 50$108.10
MA 200$104.14
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value$128.25
GradeUndervalued
TypeValue
Dividend Yield0.23%

Risk Assessment

Beta0.28
Volatility22.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.